相关实验视频

Updated: Jul 4, 2025

Assessment of the Metabolic Profile of Primary Leukemia Cells

Published on: November 21, 2018

通过METTL7B调节糖解,形成急性淋巴细胞白血病细胞增殖和化疗反应

Li Zhang¹, Xiao Liu², Shuai Zhou¹

¹Department of Human Anatomy, School of Basic Medical Sciences, Binzhou Medical University, Yantai, Shandong, China.

|January 31, 2024

概括

高METTL7B表达会使急性淋巴细胞白血病 (ALL) 的预后恶化. 削减METTL7B会抑制ALL细胞的生长,并通过向糖解来改善化学敏感性.

科学领域:

血液学血液学血液学
在瘤学瘤学.
分子生物学分子生物学

背景情况:

急性淋巴细胞白血病 (ALL) 是一种严重的血液恶性瘤,具有持续的治疗挑战.
类似甲基转移酶7B (METTL7B) 涉及固体瘤,但其在ALL中的作用尚不清楚.

研究的目的:

调查METTL7B在ALL病变发生中的作用.
探索METTL7B作为ALL的潜在治疗点.

主要方法:

在ALL患者样本中分析METTL7B表达.
在所有细胞系中对METTL7B进行基因操纵 (消耗).
评估ALL细胞的增殖和化学敏感性.
研究METTL7B对细胞糖解的影响.
评估METTL7B的甲基转移酶活性.

主要成果:

高METTL7B表达与ALL患者的预后不佳相关.
METTL7B的枯竭显著减少了ALL细胞的增殖.
抑制METTL7B可以增强ALL细胞的化学敏感性.
METTL7B调节糖解,这是ALL的一个关键代谢途径.
METTL7B的甲基转移酶活性对其对糖解和扩散的影响至关重要.

结论:

通过影响细胞代谢,METTL7B在ALL进展中起着至关重要的作用.
针对METTL7B,特别是其甲基转移酶活性,为ALL提供了一个有前途的治疗策略.
了解METTL7B的作用为ALL的代谢脆弱性提供了见解.

关键词:

急性淋巴细胞白血病 (Acute Lymphoblastic Leukemia) 是一种急性淋巴细胞白血病.化学抗药性化学抗药性是一种抗药性.化疗化疗是一种化学疗法.葡萄糖溶解是什么? 葡萄糖溶解核武器的扩散

更多相关视频

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells

Published on: July 20, 2016

相关概念视频

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...